CA
IRON icon

Clearstead Advisors’s Disc Medicine IRON Stock Holding History

Clearstead Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148 Buy
+2
New +$137 ﹤0.01% 3276
2025
Q4 		– Sell
-102
Closed -$6.74K – 3006
2025
Q3 		$6.74K Sell
102
-46
-31% -$2.74K ﹤0.01% 2053
2025
Q2 		$7.84K Buy
148
+102
+222% +$4.79K ﹤0.01% 1970
2025
Q1 		$2.28K Hold
46
– – ﹤0.01% 1880
2024
Q4 		$2.92K Hold
46
– – ﹤0.01% 1797
2024
Q3 		$2.26K Hold
46
– – ﹤0.01% 1823
2024
Q2 		$2.07K Buy
+46
New +$1.56K ﹤0.01% 1809

Other funds holding IRON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Clearstead Advisors's IRON Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Disc Medicine (IRON) in Q2 2026: 2 shares worth $148. The stake represents ﹤0.01% of the portfolio and ranks #3276 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in IRON as recently as Q3 2025.

Clearstead Advisors first reported a position in IRON in Q2 2024 and has held it in 7 quarters since. The position peaked at $7.84K in Q2 2025. 58 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Clearstead Advisors held 2 shares of Disc Medicine worth $148 as of Q2 2026.
  • Disc Medicine was a new Clearstead Advisors position in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3276 holding.
  • Clearstead Advisors first reported a position in Disc Medicine in Q2 2024 and has held it in 7 quarters since.
  • Clearstead Advisors's Disc Medicine position peaked at $7.84K in Q2 2025.
  • 58 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.